It’s crucial to know exactly how to focus the efforts of your sales team. And one of the best ways to do that is to start by seeing what’s selling.

Our HospiScope database tracks the types of medical devices, equipment and consumables that Latin American hospitals buy the most. We have 15 countries in the database right now and expect have 17 countries in the database by the end of this year.

We reviewed the data to identify the medical equipment categories that grew in different countries in Latin America between 2017 and 2018. Here’s a quick look, market by market:

Argentina (Market Size: 2,361 hospitals)

• 4% growth in infusion pumps, 2017-2018
• 5% growth in hemodialysis machines, 2017-2018

Bolivia (Market Size: 214 hospitals)

• 9% growth in C-Arms, 2017-2018
• 5% growth in colposcopes, 2017-2018

Brazil (Market Size: 6,161 hospitals)

• 8% growth in nuclear medicine systems, 2017-2018
• 2% growth in stereotactic mammography machines, 2017-2018

Chile (Market Size: 381 hospitals)

• 6% growth in endoscopy towers, 2017-2018
• 2% growth in X-ray machines, 2017-2018

Colombia (Market Size: 2,623 hospitals)

• 5% growth in endoscopy machines, 2017-2018
• 6% growth in mammography equipment, 2017-2018

Costa Rica (Market Size: 158 hospitals)

• 3% growth in C-arms, 2017-2018
• 7% growth in linear accelerators, 2017-2018

Dominican Republic (Market Size: 864 hospitals)

• 6% growth in ultrasound machines, 2017-2018
• 4% growth in C-arms, 2017-2018

Guatemala (Market Size: 163 hospitals)

• 5% growth in ultrasound machines, 2017-2018
  2.8% growth in X-ray machines, 2017-2018

Mexico (Market Size: 3,344 hospitals)

• 6.2% growth in MRI machines, 2017-2018
  17.7% growth in angiogram systems, 2017-2018

Peru (Market Size: 813 hospitals)

• 1% growth in laparoscopic surgery equipment, 2017-2018
• 4% growth in nuclear medicine systems, 2017-2018

Puerto Rico (Market Size: 67 hospitals)

• 8% growth in echocardiogram machines, 2017-2018
• 6% growth in anesthesia machines, 2017-2018

Next Steps to Sell

Of course, this is just a quick look. Our data shows that many more equipment categories posted growth in 2017-2018 as Latin American hospitals added significant amounts of base installed and capital equipment.

While knowing about these growth categories is helpful, what’s crucial is knowing which specific hospitals in these markets are acquiring this equipment and devices — and who at these hospitals handles the purchasing decisions.

This is where HospiScope can help. Subscribing to this database will uncover the buyers and allow your sales team to identify the hottest prospects for outreach.

Moreover, HospiScope data allows you to conduct sales propension analysis so as to predict which accounts have the best potential in the coming months — or years.

Contact us for a demo of HospiScope so you can see how strategic data will spike your sales of medical equipment and devices in Latin America.

We noticed this while conducting healthcare research projects for different companies, and this led to us create HospiScope to track information about Latin American hospitals, as well as ShareScope for market data and In-Scope for more specific market intelligence work.

Obviously this blog is one of the ways we used to start promoting a freer flow of information in what has been kind of a data desert, but lately we have been publishing even more complimentary resources about Latin America’s medical devices and equipment market, as well as LatAm’s healthcare system.

Since you may not have heard of all of them, we wanted to let you know about them and give you direct access to them in one place.

#1 Ranking of the Best-Equipped Hospitals in Latin America, 2017

Using HospiScope data, this list shows which hospitals offer the best infrastructure in several categories, including accommodating newborns, diagnostic imaging and cardiovascular health.

#2: Latin American Hospitals Infographic

Essential data about LatAm’s hospital ecosystem offered in a handy infographic for easy reference.

#3 Whitepaper: 5 Mega-Trends in Latin American Healthcare

A highly detailed 40-page whitepaper that not only tracks some huge changes that are impacting LatAm medical care but also highlights which medical equipment and device categories are growing the most in different hospital markets during 2017, such as Argentina, Brazil, Chile, Colombia, Costa Rica, Dominican Republic Guatemala, Mexico and Peru, among others.
Easy organization makes this a great reference resource for Latin American hospital administrators, marketing and sales teams for medical device/equipment manufacturers targeting Latin America and healthcare professionals.

#4 Infographic: Data Portrait of the Medical Equipment Market in Latin America

Organized in 3 main sections, this comprehensive (50+ data points) infographic offers 2017 import data on medical equipment/devices for all of LatAm, key numbers on 2017 imports in specific markets, equipment counts for key categories in LatAm and in large and small markets in the region, as well as technology penetration data.

#5 Report: 2018 Latin American Hospital Fact Sheets

Covering 14 countries, this report offers incisive at-a-glance breakdowns on hospital infrastructure for LatAm countries, penetration rates of installed equipment in different areas and numbers on IT infrastructure in Latin American hospitals.

WHAT’S NEXT

During the summer of 2018 GHI will release its 2018 ranking of the best-equipped hospitals in Latin America, as well as infographics on surgical procedures performed in the region’s hospitals, videos, and import data for 2018, among other resources to help professionals have a detailed understanding of Latin American healthcare resources.

The growth in the market is promising and currently accounts for ~5% of the medical device market, and is anticipated to capture more than 25% market over the next few years. Platforms are the budding part of the connected medical devices market. Few platforms are needed when compared to processors or sensors, the platforms represent aggregation points for data gathered from network endpoints.

However, as the number of on-premise and cloud solutions for collecting and analyzing device data increase so does the importance and value of platforms. The Internet of Things (IoT) is beneficial for the Connected Medical Devices market where new opportunities are abundant for current medical device manufacturers and connectivity specialists. Suppliers of sensors, platforms and processors are partnering with device manufacturers and service providers to address escalating demand for clinical devices. Also, regulatory reforms by the FDA and other agencies are creating new opportunities for device manufacturers.

Despite its early stage, Connected Medical Devices market provides a sturdy base for other enabling technologies- connecting new and existing devices with either embedded processors or radio technologies, or external connectivity gateways. Connected Medical Devices should benefit the Embedded Processors market segment, where multiple microprocessors and microcontrollers are used by system integrators and OEM manufacturers. The sensor segment is expanding rapidly (24.9% CAGR) as new applications are deployed across device segments. In addition to the diversity of applications and participants in the Embedded Processors marketplace, chipset manufacturers provide multiple processor configurations, each adaptable to multiple designs for connected medical devices.

The North America region has the highest share in the market, with the United States being the major contributor. However, markets such as the Asia- Pacific are promising to exhibit the fastest growth in the forecast period. Factors such as a large patient base and increasing investments in healthcare sectors in countries like China and Japan are proving favorable for the market growth. Despite the increasing competition, the neurostimulation devices market will continue to be dominated by North America owing to factors such as continual support and interest of global investors thanks to the advances in technology and the government’s increased focus on improving patient safety and procedure efficiency by using neurostimulation devices.

The major players in the market include St Jude Medical, Medtronic, Boston Scientific, Aleva Neurotherapeutics, Cogentix Medical, Depuy Synthes Companies, Dr. Langer Medical GMBH, EBS Technologies, Intrapace, Neurological Surgery PC, Neuronetics, Nevro, and the Magstim Company.

The Peruvian medical device and equipment market exhibited 13% growth from 2014 to 2016, going from 333 million units to 428 million units. The market value, meanwhile, remained stable at just over $435 million, indicative of the Peruvian sol’s depreciation and cost pressures being faced by manufacturers and distributors across the region.

Download the complete report for more information.

Go Further

While our report offers a strong handle on these growth within Peru, it won’t let you know equipment counts for specific hospitals in Peru so you can see which ones offer the best sales opportunities. For that, you need the deep granular detail available in our hospital database, which lets you see equipment counts for Peru’s hospitals, key contacts for purchase and much more. Contact us to subscribe to our database so you can get started today on uncovering new sales from the Peruvian hospital market.

Beyond that, we can also help with fresh data on LatAm medical equipment market share so you can see where you stand in comparison to your competitors or deliver some custom LatAm healthcare market research to further help you edge out the competition with crucial market intelligence.

Chronic allergy can last up to three months and in many cases, is recurrent despite the treatments that the patient has undergone. The INER observed that prevalence of allergies in Latin America particularly in Mexico is similar to the numbers reported in highly industrialized countries.

For some types of allergies, the numbers in Mexico is slightly above the global average. According to research in Ciudad Victoria, Tijuana, Mexicali and Monterrey, rhinitis affects 27% of the children between six to seven years and 43% of adolescents aged 13-14years. The category of antihistamines to treat allergies in Mexico reports sales of USD42.2 million and three million units each year.

Unimexicali

The study notes that EPSs from the contributory scheme remain the largest debtors of hospitals with USD2.9bn, or 40% of total debt. Second is the EPS of the subsidized regime, with 32.5% of the debt, followed by the State (including territorial entities and the Fosyga) with USD742,706mn. The remaining money is owed by companies of prepaid medicine, insurers Soat, magisterio, IPS, companies and individuals.

The ACHC pointed out that in the face of this “critical” situation, the government must guarantee the payment of debts of entities in liquidation such as Saludcoop and Caprecom and those of the newly sold Cafesalud EPS, which represent 67% of non-performing loans, to avoid detriment to the country’s health sector.

Each integral nuclear medicine center is expected to cost more than USD50 million and will work in coordination with the Center for Research and Development of Nuclear Technology to be installed in El Alto. The centers will be installed with the support of the Russian company Rosatom.

This nuclear research center will be contributing radioactive atoms to detect the cancer. Cancer detection can be performed in Bolivia and people will no longer have to travel to other countries for detection and treatment. The South American country plans to invest approximately USD 1 billion for the construction of hospitals for the next two years.

A geriatric population suffering from multiple diseases is creating a shift in the home care market towards a more precision-based personal care model.

Download the complete report for more information.

• Number of hospitals: 67
• Number of hospital beds per hospital (average): 129
• Operating rooms per hospital (average): 3.3

Penetration of:

• Ventilators: 124%
• Infusion pumps: 1254%
• MRI: 54%
• PET: 37%
• PACS: 66%
• Ultrasound: 64%

Procedure types:

• Ambulatory: 80%
• Hospitalization: 20%

Download the complete report for more information.